Carstensen Bendix, Jørgensen Marit Eika, Friis Søren
Clinical Epidemiology, Steno Diabetes Center, Gentofte, Denmark,
Curr Diab Rep. 2014 Oct;14(10):535. doi: 10.1007/s11892-014-0535-8.
The literature on cancer occurrence in persons with diabetes has almost invariably been concerned with relative measures. In this paper, we briefly review this, but the aim is to quantify the absolute occurrence of diabetes and cancer in the population in order to give a fuller picture, which also includes the competing mortality risk. Overall, we find that some 35 % of the population will have a diagnosis of diabetes in their lifetime, 44 % a diagnosis of cancer, and about 15 % will have both diagnoses. The impact of differing mortality between persons with and without diabetes is illustrated by the fact that a person without diabetes at age 50 has a smaller lifetime risk of cancer than a person aged 50 with diabetes. Thus, the differences in cancer occurrence between persons with and without diabetes are of quantitatively smaller importance than the differences in mortality.
关于糖尿病患者癌症发生情况的文献几乎一直都关注相对指标。在本文中,我们简要回顾这方面内容,但目的是量化人群中糖尿病和癌症的绝对发生率,以便更全面地了解情况,其中还包括相互竞争的死亡风险。总体而言,我们发现约35%的人在一生中会被诊断患有糖尿病,44%会被诊断患有癌症,约15%的人会同时有这两种诊断。50岁无糖尿病者的终身患癌风险低于50岁患糖尿病者,这一事实说明了糖尿病患者与非糖尿病患者死亡率差异的影响。因此,糖尿病患者与非糖尿病患者在癌症发生率上的差异,在数量上的重要性低于死亡率差异。